// App-Quantinova.ai

TCT-221 : Treatment Recommendations Based on SYNTAX Score II and Observed 3-year Mortality in the EXCEL Trial

Researchers

Presenter

  • Patrick Serruys

Principal Investigators

  • Carlos Collet

  • Yoshinobu Onuma

  • Marie-angele Morel

  • Ovidiu Dressler

  • Yiran Zhang

  • Martin Leon

  • Marie-Claude Morice

  • Philippe Genereux

  • David Kandzari

  • A. Pieter Kappetein

  • Joseph Sabik

  • Gregg Stone

Medical Centers

  • Piedmont Heart Institute, Atlanta, Georgia, United States

  • NYP-Columbia, New York, New York, United States

  • CERC, Massy, France

  • Department of Cardiothoracic Surgery, Erasmus University Medical Center, Rotterdam, Netherlands

  • Columbia University Medical Center/NewYork-Presbyterian Hospital, New York, New York, United States

  • Imperial College, London, United Kingdom

  • Cardialysis, Rotterdam, Netherlands

  • Cardiovascular Research Foundation, New York, New York, United States

  • Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio, United States

  • VUmc, Amsterdam, Netherlands

  • Thorax Center, Erasmus Medical Center, Rotterdam, Netherlands

Locations

  • United States

  • Netherlands

  • France

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxyzine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved